Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.990
+0.210 (7.55%)
Nov 4, 2024, 4:00 PM EST - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 862 employees as of December 31, 2023. The number of employees decreased by 168 or -16.31% compared to the previous year.
Employees
862
Change (1Y)
-168
Growth (1Y)
-16.31%
Revenue / Employee
$520,176
Profits / Employee
-$19,194
Market Cap
396.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ZimVie | 2,600 |
| Ginkgo Bioworks Holdings | 1,218 |
| Amylyx Pharmaceuticals | 384 |
| AirSculpt Technologies | 381 |
| Esperion Therapeutics | 240 |
| Akebia Therapeutics | 167 |
| 4D Molecular Therapeutics | 147 |
| MaxCyte | 143 |
ORGO News
- 20 days ago - Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 4 weeks ago - Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 3 months ago - Organogenesis Holdings, Inc. (ORGO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Organogenesis Shares ReNu® Program Update - GlobeNewsWire
- 4 months ago - Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024 - GlobeNewsWire
- 5 months ago - Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference - GlobeNewsWire
- 6 months ago - Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript - Seeking Alpha